A sea of paperwork or business as usual?
April 30, 2008Medical Communications, Sales and Marketing 2008, ABPI, UK, code, marketing, pharma
Tamiflu takes the shine off Roche results
April 24, 2008Sales and Marketing
Falling sales of its blockbuster flu treatment Tamiflu have dented Roche's balance sheet. The Swiss company managed sales of 10.9 …
Roche’s new RA treatment gains first approval
April 24, 2008Sales and Marketing
Roche's Actemra has been given its first green light, gaining marketing approval in Japan for the treatment of rheumatoid arthritis.Actemra …
Vaccination drive halts meningitis deaths
April 22, 2008The national meningitis vaccination programme successfully prevented any deaths in young people in England last year, according to a new …
Lipitor loses out on Alzheimer’s lifeline
April 22, 2008Research and Development
Pfizer's blockbuster statin Lipitor has shown no impact on the treatment of Alzheimer's disease, scotching the company's hopes for a …
Polyclinics ‘threaten’ traditional surgeries
April 22, 2008The Conservatives have attacked government efforts to reform the health service, warning that plans for new polyclinics will endanger the …
Can your brand stand out in a crowd?
April 21, 2008Sales and Marketing branding, marketing
The 'value proposition' is a good example. It is a buzz-word used by marketers the world over, and yet far …
United Drug expands with two acquisitions
April 18, 2008Business Services, Manufacturing and Production
United Drug has broadened its reach with two new acquisitions, one in meetings and events and another in the field …
Latest news from Datamonitor
April 18, 2008Sales and Marketing
Novartis eyes Alcon to drive diversification strategy Novartis has agreed to acquire a controlling stake in ophthalmology specialist Alcon for …
NHS accountability debate ‘lacks clarity’
April 17, 2008A leading thinktank has criticised what it calls a lack of clarity in the debate over accountability in the NHS. …
AZ settles with generic challenger to Nexium
April 17, 2008Sales and Marketing
AstraZeneca has settled its legal battle with Indian generics company Ranbaxy Laboratories over the US patents on Nexium, AstraZeneca's biggest …
Shire plans tax move to Ireland
April 17, 2008Sales and Marketing
One of the UK's leading pharmaceutical companies is to shift its tax base to the Republic of Ireland to benefit …
Roche to buy Piramed
April 15, 2008Sales and Marketing MA, Piramed
Roche is set to pay $160 million (£315 million) to buy UK biotech company Piramed, a move which will further …
Olympian projects require world-class planning
April 14, 2008Research and Development clinical trials, project planning
The latest edition of the CMR International R&D Factbook shows that the mean time from protocol approval to final report …
Boehringer Ingelheim outpaces market
April 14, 2008Sales and Marketing resp
Strong growth in respiratory product Spiriva once again led the way for Boehringer Ingelheim, which has just published results for …
NHS poll shows shortfall in care and hand washing
April 14, 2008Less than half of NHS staff believes patient care is a top priority for trusts, according to a survey from …
Takeda buys up biotech Millennium
April 14, 2008Sales and Marketing
Takeda has acquired US biotech company Millennium in an effort to boost its global presence in oncology. The Japanese firm …
Merck obesity drug to continue at low dose
April 11, 2008Research and Development, Sales and Marketing
New data suggests Merck's taranabant drug can help obese patients lose weight, but safety concerns look to be behind higher …
Study confers protective benefits on Micardis
April 4, 2008Sales and Marketing cv
Boehringer Ingelheim's hypertension treatment Micardis has come out on top of Aventis's gold standard ACE inhibitor Tritace in a new …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
